Download FREE Report Sample
Download Free sampleGene silencing is the regulation of gene expression in a cell to prevent the expression of a certain gene. Gene silencing can occur during either transcription or translation and is often used in research.In particular, methods used to silence genes are being increasingly used to produce therapeutics to combat cancer and diseases, such as infectious diseases and neurodegenerative disorders.
Gene Silencing Market contains market size and forecasts of Gene Silencing in Global, including the following market information:
Global Gene Silencing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Gene Silencing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Transcriptional Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gene Silencing include Alnylam Pharmaceuticals, Benitec Biopharma, Arrowhead Pharmaceuticals, Merck Group, Eli Lilly (Dicerna Pharmaceuticals), Monsanto (Bayer AG), RXi Pharmaceuticals, Silence Therapeutics plc and Idera Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene Silencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Silencing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Gene Silencing Market Segment Percentages, by Type, 2021 (%)
Transcriptional
Post-transcriptional
Meiotic
Global Gene Silencing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Gene Silencing Market Segment Percentages, by Application, 2021 (%)
Cancer Treatment
Neurological Diseases Treatment
Scar Treatment
Other
Global Gene Silencing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Gene Silencing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Silencing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Gene Silencing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alnylam Pharmaceuticals
Benitec Biopharma
Arrowhead Pharmaceuticals
Merck Group
Eli Lilly (Dicerna Pharmaceuticals)
Monsanto (Bayer AG)
RXi Pharmaceuticals
Silence Therapeutics plc
Idera Pharmaceuticals
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
